ALOPECIA AREATA
Clinical trials for ALOPECIA AREATA explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Head-to-Head hair regrowth trial: can common drugs reverse severe baldness?
Disease control Not yet recruitingThis study will compare two existing oral medications—tofacitinib and methotrexate—for treating severe forms of alopecia areata, an autoimmune condition causing significant hair loss. Seventy-eight adults with severe hair loss will take one of the medications for 12 weeks to see …
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cream vs. shots: which works better for hair regrowth?
Disease control Not yet recruitingThis study compares two treatments for patchy hair loss caused by alopecia areata. Sixty adults will use either a topical vitamin D cream or receive steroid injections into the scalp for 12 weeks. Researchers will measure which treatment helps hair grow back better and has fewer …
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Does the new hair loss drug work outside the lab?
Disease control Not yet recruitingThis study aims to see how well the approved drug ritlecitinib works for people with severe alopecia areata (an autoimmune condition causing hair loss) in real-world settings. It will look back at the medical records of about 300 people in the U.S. who started the treatment to un…
Matched conditions: ALOPECIA AREATA
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New gel vs. spray: Head-to-Head test for hair regrowth
Disease control Not yet recruitingThis study aims to find out which of two existing topical treatments works better for patchy hair loss caused by alopecia areata. About 268 adults with limited scalp patches will be randomly assigned to use either a methotrexate gel or a minoxidil spray for 24 weeks. Researchers …
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Jinnah Postgraduate Medical Centre • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Massive italian study to map skin disease treatment patterns
Knowledge-focused Not yet recruitingThis study will analyze existing medical records from 20,000 Italian patients with psoriasis, eczema, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers aim to understand how these conditions are treated in real-world practice and how patients' health evolves ove…
Matched conditions: ALOPECIA AREATA
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC